Most psychotropic prescribing for children falls to non-specialists—a child psychiatrist shares hard-won pearls on dosing, consent, and family dynamics.
Dr. Brody tackles maintenance dosing, withdrawal risks, borderline personality response, and a controversial negative trial making waves in psychiatry.
Researchers evaluate an online calculator estimating suicide risk for patients with bipolar disorder or schizophrenia spectrum conditions, examining its predictive validity.
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of Psych Partners. He maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?t=1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
